Comparison of programmed death-ligand 1 protein expression between primary and metastatic lesions in patients with lung cancer

Comparison of programmed death-ligand 1 protein expression between primary and metastatic lesions in patients with lung cancer

Assessment of programmed cell death-ligand 1 (PD-L1) expression by immunohistochemistry (IHC) is the definite diagnostic test to guide treatment for patients with advanced-stage non-small cell lung cancer. Intratumoral heterogeneity and discrepancy of PD-L1 expression between primary and metastatic...

Full description

Bibliographic Details
Main Authors: Lajos Pusztai, Richard Huang, Shakti Ramkissoon, Jeffrey S Ross, Konstantinos Syrigos, Myrto K Moutafi, Weiwei Tao, James Haberberger, Ioannis A Vathiotis
Format: Article
Language:English
Published: BMJ Publishing Group 2021-04-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/9/4/e002230.full

Internet

https://jitc.bmj.com/content/9/4/e002230.full

Similar Items